Fuzzy-CNN IFA Analysis for Scalable Nasopharyngeal Cancer Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional immunofluorescence assays (IFA) for disease detection, particularly nasopharyngeal cancer (NPC) and autoimmune diseases, require human interpretation and are not scalable due to their reliance on expert evaluation, leading to poor standardization and high false negative rates in scalable alternatives like ELISA and qPCR.
Innovation Solution
An automated disease detection system (DDS) that mimics human expert evaluation by using a combination of fuzzy inference systems and convolutional neural networks to analyze immunofluorescence assay images, reducing the need for human interpretation and improving scalability and accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional IFA methods are used for disease screening, then detection sensitivity and accuracy are improved, but scalability and standardization deteriorate due to reliance on human expert interpretation
Solution Approach 1:
The patent replaces the mechanical system of human visual interpretation with an automated image analysis system using convolutional neural networks. The CNN-based automated reading system processes IFA images objectively, eliminating the need for human expert interpretation while maintaining high detection sensitivity and enabling scalable disease screening.
Solution Approach 2:
The patent creates a digital copy of the human expert's interpretation capability through machine learning models. The CNN system is trained to replicate the pattern recognition abilities of human experts, producing standardized readings that can be scaled indefinitely without requiring additional human expertise.
2Measurement precision
If human expert interpretation is used in IFA, then detection accuracy is improved, but time consumption and operational complexity increase
Solution Approach 1:
The patent substitutes the time-consuming human interpretation process with an automated computational system. The CNN-based automated reading system rapidly processes IFA images, delivering accurate results in seconds or minutes compared to the hours required for manual expert review, thereby significantly reducing time consumption while maintaining high detection accuracy.
3Productivity
If scalable methods like ELISA and qPCR are used instead of IFA, then productivity and standardization are improved, but detection sensitivity deteriorates with high false negative rates
Solution Approach 1:
The patent merges the high sensitivity advantage of conventional IFA with the scalability advantage of automated systems. By combining the immunofluorescence assay methodology with automated CNN-based image analysis, the system achieves both high detection sensitivity (low false negative rate) and scalability, overcoming the limitations of both conventional manual IFA and alternative scalable methods like ELISA and qPCR.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The DDS achieves high agreement with human pathologists in identifying cellular patterns, enhancing scalability and accuracy with near-perfect agreement and reduced false negatives, allowing for precise quantitative output and flexible decision boundaries.
Implementation Method 1
the detection of secretory IgA antibodies to the EA complex in patient sera is a highly-sensitive and specific biomarker for NPC
Data Source
AI summary
The present invention relates to the provision of an automated system and a computer-implemented method for detecting a disease such as nasopharyngeal cancer (NPC) based upon the use of either a Fuzzy Inference (FI) system or a deep learning-fuzzy inference (DeLFI) hybrid model to analyse immunofluorescence assay (IFA) images. For NPC detection, the system and method of the invention would distinguish between Epstein Barr Virus (EBV) Early Antigen (EA) positive and negative cells, and identify cellular patterns which are indicative of NPC. The DeLFI hybrid model requires less human evaluation and thereby has the potential to improve the scalability and accuracy of NPC detection.